Pediatr. praxi. 2020;21(3):192-195 | DOI: 10.36290/ped.2020.039

Postnatal antibiotic chemoprophylaxis does not have to prevent a devastating GBS neuroinfection in the newborn

MUDr. Kristýna Boráková, prof. MUDr. Zbyněk Straňák, CSc., MBA
Ústav pro péči o matku a dítě, Praha

The case study demonstrates the complexity and severity of the perinatal infection caused by Streptococcus agalactiae (GBS). The vertical transmission of GBS to a newborn occurred in a GBS negative mother. The neonate with muco-cutaneous GBS colonization and without signs of GBS sepsis was treated prophylactically using antibiotics. However chemoprophylaxis did not prevent developing severe and devastating neuroinfection (late onset GBS infection). Current preventive measures (screening of GBS in pregnancy, antibiotic chemoprophylaxis in GBS positive mothers, stratified infection monitoring in newborns, prophylactic treatment in high-risk newborns) have led to a significant reduction in the early neonatal GBS sepsis. The incidence of late invasive GBS infections has not been influenced by these approaches and the introduction of additional strategies to eliminate GBS complications is a priority and an imperative of perinatal care.

Keywords: Streptococcus agalactiae (GBS), early‑onset and late‑onset neonatal sepsis, GBS meningitis.

Published: June 3, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boráková K, Straňák Z. Postnatal antibiotic chemoprophylaxis does not have to prevent a devastating GBS neuroinfection in the newborn. Pediatr. praxi. 2020;21(3):192-195. doi: 10.36290/ped.2020.039.
Download citation

References

  1. Puopolo KM, Lynfield R, Cummings JJ. Management of Infants at Risk for Group B Streptococcal Diseases. Pediatrics, 2019; 144(2): e20191881. Go to original source... Go to PubMed...
  2. Online ACOG publications.Prevention of Group B Streptococcal Early‑Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstet Gynecol, 2020; 135(2): e51-e72. Dostupné z: doi: 10.1097/AOG.0000000000003668. Go to original source... Go to PubMed...
  3. Randis TM, Baker JA, Ratner AJ. Group B Streptococcal Infections. Pediatr Rev, 2017; 38(6) 254-262. Go to original source...
  4. Gagneur A, Héry‑Arnaud G, Croly‑Labourdette S, et al. Infected breast milk associated with late‑onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr, 2009; 168(9): 1155-1158. Go to original source...
  5. Zimmermann P, Gwee A, Curtis N. The controversial role of breast milk in GBS late‑onset disease. J Infect, 2017; 74 Suppl 1: vS34-S40. Go to original source...
  6. Puopolo KM, Madoff LC, Eichenwald EC. Early‑onset group B streptococcal disease in the era of maternal screening. Pediatrics, 2005; 115(5): 1240-1246. Go to original source... Go to PubMed...
  7. Benitz WE. Adjunct laboratory tests in the diagnosis of early‑onset neonatal sepsis. Clin Perinatol, 2010; 37(2): 421-438. Go to original source... Go to PubMed...
  8. Tibussek D, Sinclair A, Yau I, et al. Late‑onset group B streptococcal meningitis has cerebrovascular complications. J Pediatr, 2015; 166(5): 1187-1192.e1. Go to original source... Go to PubMed...
  9. Libster R, Edwards KM, Levent F, et al. Long‑term outcomes of group B streptococcal meningitis. Pediatrics. 2012; 130(1): e8-15. Go to original source... Go to PubMed...
  10. Bartlett AW, Smith B, George CR, et al. Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen‑Year Experience From Two Australian Tertiary Pediatric Facilities. Pediatr Infect Dis J, 2017; 36(1): 20-24. Go to original source... Go to PubMed...
  11. Shoda T, Miyagi N, Shirai K, et al. Double recurrence of group B streptococcus bacteremia in an immunocompetent infant. Pediatr Int, 2012; 54(5): 701-703. Go to original source... Go to PubMed...
  12. Soukka H, Rantakokko‑Jalava K, Vähäkuopus S, et al. Three distinct episodes of GBS septicemia in a healthy newborn during the first month of life. Eur J Pediatr, 2010; 169(10): 1275-1277. Go to original source...
  13. Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococus vaccine: state of the art. Ther Adv Vaccines, 2015; 3(3): 76-90. Go to original source...
  14. Lin FY, Weisman LE, Troendle J, et al. Prematurity Is the Major Risk Factor for Late‑Onset Group B Streptococcus Disease. J Infect Dis, 2003; 188(2): 267-271. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.